AAAAAA

   
Results: 1-9 |
Results: 9
Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure
Authors: Suzuki, J Ohta, H Hanada, K Kawai, N Ikeda, T Nakao, M Ikemoto, F Nishikibe, M
Citation: J. Suzuki et al., Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure, HYPERTENS R, 24(1), 2001, pp. 65-74
Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing
Authors: Tadano, K Suzuki, J Hanada, K Nakao, M Nakao, R Uehara, S Ohta, H Miyauchi, T Nishikibe, M
Citation: K. Tadano et al., Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing, J PHARM EXP, 298(2), 2001, pp. 729-736
Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A novel muscarinic antagonist with M-2-sparing antagonistic activity
Authors: Hirose, H Aoki, I Kimura, T Fujikawa, T Numazawa, T Sasaki, K Sato, A Hasegawa, T Nishikibe, M Mitsuya, M Ohtake, N Mase, T Noguchi, K
Citation: H. Hirose et al., Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A novel muscarinic antagonist with M-2-sparing antagonistic activity, J PHARM EXP, 297(2), 2001, pp. 790-797
Marked reduction of mortality in salt-loaded Dahl salt-sensitive rats by the new, selective endothelin ETA receptor antagonist, J-105859
Authors: Okada, M Nishino, M Saito, M Ikeda, T Uehara, S Okada, H Niiyama, K Ohtake, N Hayama, T Nishikibe, M
Citation: M. Okada et al., Marked reduction of mortality in salt-loaded Dahl salt-sensitive rats by the new, selective endothelin ETA receptor antagonist, J-105859, J HYPERTENS, 18(12), 2000, pp. 1815-1823
Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1-receptor antagonist,MK-954
Authors: Ikeda, T Ohta, H Okada, M Kawai, N Nakao, R Siegl, PKS Kobayashi, T Miyauchi, T Nishikibe, M
Citation: T. Ikeda et al., Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1-receptor antagonist,MK-954, J CARDIO PH, 36, 2000, pp. S337-S341
Antithrombotic activity of NSP-513, a novel selective phosphodiesterase 3 inhibitor, on femoral arterial thrombosis induced by physical stenosis and electrical current: Comparison of antithrombotic and hemodynamic effects
Authors: Hirose, H Mashiko, S Kimura, T Ishida, F Mochizuki, N Nishibe, T Nishikibe, M
Citation: H. Hirose et al., Antithrombotic activity of NSP-513, a novel selective phosphodiesterase 3 inhibitor, on femoral arterial thrombosis induced by physical stenosis and electrical current: Comparison of antithrombotic and hemodynamic effects, J CARDIO PH, 35(4), 2000, pp. 586-594
Antiplatelet and antithrombotic effects of a novel selective phosphodiesterase 3 inhibitor, NSP-513, in mice and rats
Authors: Hirose, H Kimura, T Okada, M Itoh, Y Ishida, F Mochizuki, N Nishibe, T Nishikibe, M
Citation: H. Hirose et al., Antiplatelet and antithrombotic effects of a novel selective phosphodiesterase 3 inhibitor, NSP-513, in mice and rats, JPN J PHARM, 82(3), 2000, pp. 188-198
Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension
Authors: Ikeda, T Ohta, H Okada, M Kawai, N Nakao, R Siegl, PKS Kobayashi, T Maeda, S Miyauchi, T Nishikibe, M
Citation: T. Ikeda et al., Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension, HYPERTENSIO, 34(3), 1999, pp. 514-519
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist
Authors: Nishikibe, M Ohta, H Okada, M Ishikawa, K Hayama, T Fukuroda, T Noguchi, K Saito, M Kanoh, T Ozaki, S Kamei, T Hara, K William, D Kivlighn, S Krause, S Gabel, R Zingaro, G Nolan, N O'Brien, J Clayton, F Lynch, J Pettibone, D Siegl, P
Citation: M. Nishikibe et al., Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist, J PHARM EXP, 289(3), 1999, pp. 1262-1270
Risultati: 1-9 |